Health Care & Life Sciences » Biotechnology | United Therapeutics Corp.

United Therapeutics Corp.

United Therapeutics Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
43.56 M
Public Float
38.02 M
United Therapeutics Corp.
Stock Exchange NASDAQ Stock Market
EPS
$3.44
Market Cap
$3.51 B
Shares Outstanding
43.81 M
Public Float
42.36 M

Profile

Address
1040 Spring Street
Silver Spring Maryland 20910
United States
Employees -
Website http://www.unither.com
Updated 07/08/2019
United Therapeutics Corp. biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. It also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies.

Financials

View All
Created with Highcharts 5.0.14United Therapeutics Corp.Net Income. Fiscal year is January-December. All values USD Millions.1751753403406526527147144184185895892013201420152016201720180200400600800
Created with Highcharts 5.0.14United Therapeutics Corp.Sales/Revenue. Fiscal year is January-December. All values USD Millions.1 1171 1171 2891 2891 4661 4661 5991 5991 7251 7251 6281 6282013201420152016201720180500100015002000

Martine A. Rothblatt
Chairman & Chief Executive Officer
Raymond Allen Dwek
Non-Independent Director